
It is no secret that Milan was not best pleased that it was pipped to the post to host the …

In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …

Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …

Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective …

The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …

While the EMA’s Committee for Medicinal products for Human Use (CHMP) recommended a spree of treatments over the past week, …

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …

The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …

The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …

Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …

An advisory panel of the FDA has judged that US tobacco firm Philip Morris International (PMI) has not been able …

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …